HU202745B - Process for producing pharmaceutical compositions acting on the skin or percutaneously on the organism, having increased penetration capacity and comprising liposomes as active ingredient carrier - Google Patents

Process for producing pharmaceutical compositions acting on the skin or percutaneously on the organism, having increased penetration capacity and comprising liposomes as active ingredient carrier Download PDF

Info

Publication number
HU202745B
HU202745B HU865007A HU500786A HU202745B HU 202745 B HU202745 B HU 202745B HU 865007 A HU865007 A HU 865007A HU 500786 A HU500786 A HU 500786A HU 202745 B HU202745 B HU 202745B
Authority
HU
Hungary
Prior art keywords
skin
liposomes
active ingredient
pharmaceutical compositions
process according
Prior art date
Application number
HU865007A
Other languages
English (en)
Other versions
HUT42943A (en
Inventor
Josef Mueller
Original Assignee
Roehm Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roehm Pharma Gmbh filed Critical Roehm Pharma Gmbh
Publication of HUT42943A publication Critical patent/HUT42943A/hu
Publication of HU202745B publication Critical patent/HU202745B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (8)

  1. SZABADALMI IGÉNYPONTOK
    1. Eljárás fokozott penetrációs képességű, hatóanyaghordozóként koleszterin - lecitin felépítésű liposzómákat tartalmazó gyógyszerkészítmények előállítására, mimellett a dermálisan, illetve transz- 30 dermálisan adagolható hatóanyagok a liposzómákban oldott, emulgeált, vagy szuszpendált állapotban találhatók, azzal jellemezve, hogy penetrációfokozó anyagként 2-20 tömeg% karbamidot alkalmazunk. 35
  2. 2. Az 1. igénypont szerinti eljárás, azzal jellemezve, hogy hatóanyagként kortikoidot alkalmazunk.
  3. 3. Az 1. igénypont szerinti eljárás, azzal jellemezve, hogy hatóanyagként antracéntriolt alkalma- 40 zunk.
  4. 4. Az 1 -3. igénypontok bármelyike szerinti eljárás, azzal jellemezve, hogy hatóanyagkeveréket tartalmazó gyógyszerkészítményeket állítunk elő.
  5. 5. Az 1-4. igénypontok bármelyike szerinti eljárás, azzal jellemezve, hogy hatóanyagkeverékként kor tikoid-antracéntriói keveréket alkalmazunk.
  6. 6. Az 1-3., vagy 4-5. igénypontok bármelyike szerinti eljárás, azzal jellemezve, hogy kortikoidként triamcinolont alkalmazunk.
  7. 7. Az 1. vagy 3-5. igénypontok bármelyike szerinti eljárás, azzal jellemezve, hogy antracéntriolként dithranolt alklamazunk.
  8. 8. Az 1-7. igénypontok bármelyike szerinti eljárás, azzal jellemezve, hogy 0,1-3 tömeg% hatóanyagot tartalmazó gyógyszerkészítményeket állítunk elő.
    Kiadja: Országos Találmányi Hivatal, Budapest Felelős kiadó: dr. Szvoboda Gabriella
HU865007A 1985-12-04 1986-12-03 Process for producing pharmaceutical compositions acting on the skin or percutaneously on the organism, having increased penetration capacity and comprising liposomes as active ingredient carrier HU202745B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853542773 DE3542773A1 (de) 1985-12-04 1985-12-04 Hautwirksame pharmaka mit liposomen als wirkstofftraeger

Publications (2)

Publication Number Publication Date
HUT42943A HUT42943A (en) 1987-09-28
HU202745B true HU202745B (en) 1991-04-29

Family

ID=6287528

Family Applications (1)

Application Number Title Priority Date Filing Date
HU865007A HU202745B (en) 1985-12-04 1986-12-03 Process for producing pharmaceutical compositions acting on the skin or percutaneously on the organism, having increased penetration capacity and comprising liposomes as active ingredient carrier

Country Status (6)

Country Link
US (1) US4954345A (hu)
EP (1) EP0224837B1 (hu)
JP (1) JPS62132819A (hu)
AT (1) ATE83653T1 (hu)
DE (2) DE3542773A1 (hu)
HU (1) HU202745B (hu)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2628317B1 (fr) * 1988-03-09 1991-11-08 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
FR2648462B1 (fr) * 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
FR2655540B1 (fr) * 1989-12-13 1994-02-11 Oreal Composition cosmetique pour le soin des cheveux et utilisation de ladite composition.
DE3941582A1 (de) * 1989-12-14 1991-06-20 Schering Ag Pharmazeutische praeparate
EP0571063A1 (de) * 1989-12-14 1993-11-24 Schering Aktiengesellschaft Pharmazeutische Präparate
US5741513A (en) * 1990-02-08 1998-04-21 A. Natterman & Cie. Gmbh Alcoholic aqueous gel-like phospholipid composition, its use and topical preparations containing it
AU652778B2 (en) * 1990-10-15 1994-09-08 Quest International B.V. Treatment composition
CA2073353C (fr) * 1990-11-14 2003-10-28 Alexandre Zysman Composes amphiphiles non-ioniques derives du glycerol, leur procede de preparation, composes intermediaires correspondants et compositions contenant lesdits composes
FR2681247B1 (fr) * 1991-09-17 1993-12-03 Oreal Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation.
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US7556825B2 (en) * 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
CZ20012038A3 (cs) * 1998-12-23 2001-09-12 Idea Ag Zdokonalený přípravek pro topické, neinvazivní použití in vivo
ES2173678T3 (es) 1999-01-27 2002-10-16 Idea Ag Vacunacion no invasiva a traves de la piel.
DK1031347T3 (da) 1999-01-27 2002-07-08 Idea Ag Transnasal transport/immunisering med meget tilpasselige bærere
MXPA02000053A (es) * 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
DE50005922D1 (de) * 2000-11-14 2004-05-06 Benkert Eugen Georg Topical-Antipsoriaticum mit Harnstoff, einem Corticoid und einem Desinfektionsmittel
DK1347743T3 (da) * 2000-12-07 2006-07-03 Univ Utrecht Holding Bv Præparat til behandling af inflammatoriske lidelser
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US20030170187A1 (en) * 2002-03-01 2003-09-11 Alfred Marchal Skin treatments containing nano-sized vitamin K
US20050152962A1 (en) * 2002-06-12 2005-07-14 Metselaar Josbert M. Composition for treatment of inflammatory disorders
EP1393720A1 (en) * 2002-08-27 2004-03-03 Universiteit Utrecht Vesicle-encapsulated corticosteroids for treatment of cancer
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
US20050002884A1 (en) * 2003-07-02 2005-01-06 Marsella Jefferson Hair treatment compositions
US20050129753A1 (en) * 2003-11-14 2005-06-16 Gabizon Alberto A. Method for drug loading in liposomes
JP2008519784A (ja) * 2004-11-12 2008-06-12 イデア アクチェンゲゼルシャフト 皮膚状態の治療における拡張表面凝集体
US20100273203A1 (en) * 2009-04-23 2010-10-28 Board Of Trustees Of The University Of Arkansas Methods and compositions for detecting metabolites
US8410064B2 (en) * 2009-08-24 2013-04-02 The Board Of Trustees Of The University Of Arkansas Classical cannabinoid metabolites and methods of use thereof
US8883218B2 (en) * 2010-03-26 2014-11-11 The Board Of Trustees Of The University Of Arkansas Anti-cancer nanoparticle compositions and methods of use
US9095598B2 (en) 2010-12-28 2015-08-04 The Board Of Trustees Of The University Of Arkansas Stilbenoid derivatives and their uses
FR2979239A1 (fr) * 2011-08-25 2013-03-01 Trophos Liposome comprenant au moins un derive de cholesterol
US9365856B2 (en) 2012-09-14 2016-06-14 The Board Of Trustees Of The University Of Arkansas Methods of using a serum response factor isoform
WO2015031645A1 (en) 2013-08-28 2015-03-05 Washington University Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon sv
US9487536B2 (en) 2013-11-08 2016-11-08 Board Of Trustees Of The University Of Arkansas Melampomagnolide B derivatives
US9469650B2 (en) 2013-11-08 2016-10-18 Board Of Trustees Of The University Of Arkansas Melampomagnolide B derivatives
WO2015171591A1 (en) 2014-05-05 2015-11-12 Board Of Trustees Of The University Of Arkansas COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS
WO2016014625A1 (en) 2014-07-22 2016-01-28 Board Of Trustees Of The University Of Arkansas Compositions and methods for selectively depleting senescent cells
US10449261B2 (en) 2014-07-24 2019-10-22 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
US10905763B2 (en) 2014-09-10 2021-02-02 Washington University Compositions and methods for treatment of pre-cancerous skin lesions
WO2016064832A1 (en) 2014-10-20 2016-04-28 The Curators Of The University Of Missouri Method for treating lymphedema
WO2016090166A1 (en) 2014-12-03 2016-06-09 Board Of Trustees Of The University Of Arkansas Melampomagnolide b dimers
EP4382535A2 (en) 2014-12-15 2024-06-12 Washington University Compositions and methods for targeted cytokine delivery
WO2016187499A1 (en) 2015-05-20 2016-11-24 Syracuse University Improved glycemic control using intrinsic factor bound to a vitamin b12 conjugate of a glucagon-like peptide- 1 receptor agonist
US10716827B2 (en) 2015-05-20 2020-07-21 Syracuse University Compositions and methods for enhancing peptide stability against protease digestion
WO2017011728A1 (en) 2015-07-15 2017-01-19 Washington University ANTIBODIES TO TUMOR ASSOCIATED COMPLEX N-GLYCANS WITH TERMINAL GlcNAcBeta RESIDUES AND METHODS OF USE THEREOF
US20180319815A1 (en) 2015-11-05 2018-11-08 Board Of Trustees Of The University Of Arkansas Hetero-substituted cyclic lactone analogues and uses thereof
US11938193B2 (en) 2016-01-08 2024-03-26 Washington University Compositions comprising chemerin and methods of use thereof
JP2019509980A (ja) 2016-01-29 2019-04-11 バイオベンチャーズ・リミテッド・ライアビリティ・カンパニーＢｉｏＶｅｎｔｕｒｅｓ， ＬＬＣ メランポマグノリドｂのトリアゾール誘導体及びその使用方法
JP7220458B2 (ja) 2016-02-05 2023-02-10 ワシントン・ユニバーシティ 標的サイトカインデリバリーのための組成物および方法
US10213448B2 (en) 2016-03-25 2019-02-26 Novazoi Theranostics Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof
JP6936498B2 (ja) 2016-04-21 2021-09-15 バイオベンチャーズ・リミテッド・ライアビリティ・カンパニーＢｉｏＶｅｎｔｕｒｅｓ， ＬＬＣ 抗アポトーシス性Ｂｃｌ−２ファミリータンパク質の分解を誘導する化合物及びその使用
CA3034081A1 (en) 2016-08-18 2018-02-22 Troy Bremer Delivery of urea to cells of the macula and retina using liposome constructs
US11058653B2 (en) 2016-10-26 2021-07-13 Washington University Compositions comprising desaminotyrosine and uses thereof to enhance type I interferon stimulation
US11352436B2 (en) 2017-02-10 2022-06-07 Washington University Antibodies to TIP1 and methods of use thereof
WO2018201088A1 (en) 2017-04-27 2018-11-01 Washington University Activation of natural cytotoxicity receptor 2 (ncr2)
US11351227B2 (en) 2017-04-27 2022-06-07 Washington University Chemokine decoy receptors of rodent gammaherpesviruses and uses thereof
JP2020529395A (ja) 2017-06-12 2020-10-08 ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ グリオブラストーマを治療するためのジカウイルス株
WO2019028062A1 (en) 2017-07-31 2019-02-07 Washington University PIRFENIDONE DERIVATIVES FOR MODULATION OF B-LYMPHOCYTE ACTIVITY AND PROTECTION OF ORGANS
EP3668497A4 (en) 2017-08-14 2021-04-28 Washington University METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER, INFLAMMATION, OR IMMUNE-REACTION-ASSOCIATED DISEASES
US11097018B2 (en) 2017-09-06 2021-08-24 Washington University Organomedicinals for imaging and treatment of neurodegenerative disorders
JP7385284B2 (ja) 2018-01-22 2023-11-22 バイオベンチャーズ・リミテッド・ライアビリティ・カンパニー 癌処置のためのｂｃｌ－２タンパク質分解剤
US11964001B2 (en) 2019-04-09 2024-04-23 Washington University Compositions for treating or preventing respiratory tract infections and method of use thereof
US11752199B1 (en) 2020-02-25 2023-09-12 Mallinckrodt Ard Ip Unlimited Company Methods of modulating pericytes
EP3973978A1 (en) 2020-09-25 2022-03-30 Mallinckrodt Ard IP Unlimited Company Methods of modulating corticosteroid response

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957971A (en) * 1974-07-29 1976-05-18 Lever Brothers Company Moisturizing units and moisturizing compositions containing the same
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
EP0032578B1 (de) * 1980-01-16 1984-07-25 Hans Georg Prof. Dr. Weder Verfahren und Dialysiereinrichtung zur Herstellung von Bilayer-Vesikeln und Verwendung der Bilayer-Vesikel
JPS60153938A (ja) * 1984-01-23 1985-08-13 Pola Chem Ind Inc 新規なリポソ−ムの作製法
JPS60155109A (ja) * 1984-01-23 1985-08-15 Terumo Corp リポソ−ム製剤
JPS60152410A (ja) * 1984-01-23 1985-08-10 Pola Chem Ind Inc 皮膚外用剤
JPH052414A (ja) * 1991-06-24 1993-01-08 Toshiba Mach Co Ltd 工作機械の変位補正方法

Also Published As

Publication number Publication date
DE3542773A1 (de) 1987-06-11
EP0224837B1 (de) 1992-12-23
JPS62132819A (ja) 1987-06-16
US4954345A (en) 1990-09-04
EP0224837A2 (de) 1987-06-10
ATE83653T1 (de) 1993-01-15
HUT42943A (en) 1987-09-28
DE3687341D1 (de) 1993-02-04
EP0224837A3 (en) 1987-10-21

Similar Documents

Publication Publication Date Title
HU202745B (en) Process for producing pharmaceutical compositions acting on the skin or percutaneously on the organism, having increased penetration capacity and comprising liposomes as active ingredient carrier
US5147859A (en) Complexes of glycerrhetinic acid with phospholipids and pharmaceutical and cosmetic compositions containing them
EP0036676B2 (en) Method of making uniformly sized liposomes and liposomes so made
JP4203394B2 (ja) 高濃度のトリテルペノイドを含有する微小化リポソーム及びその製造方法
EP1581185B1 (de) Liposomale glucocorticoide
JPH09508900A (ja) 薬理学的に活性な化合物及びリポソーム並びにそれらの使用方法
CH668554A5 (de) Liposomen welche polypeptide mit interleukin-2-aktivitaet enthalten sowie verfahren zu ihrer herstellung.
WO1990009782A1 (en) Liposome gel composition and method
EP0152379A2 (de) Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
BRPI0615635A2 (pt) composição para aplicação externa para tratamento de doenças de pele
JP3011762B2 (ja) 医薬品
JP3187622B2 (ja) リポソーム
EP0740547B1 (de) Liposomen enthaltend darin verkapselte proteine, verfahren zu ihrer herstellung sowie diese liposomen enthaltende pharmazeutische und kosmetische zubereitungen
DE3877365T2 (de) Arzneimittel mit methylcellulose.
MXPA01006462A (es) Acido niflumico liposomico - nueva medicina antiinflamatoria transdermica.
CA2416731C (en) Liposomal formulation of clobetasol propionate
EP3145490B1 (en) Liposomes containing di-homo-gamma linolenic acid (dgla), formulations containing them and use thereof
JP2002535251A (ja) 癌治療のための新規化合物
JP2003512313A (ja) ６，９−ビス−［（２−アミノエチル）−アミノ］ベンゾ［ｇ］イソキノリン−５，１０−ジオンジマレエートのリポソーム製剤
US5817646A (en) Polar lipid composition of plant origin
JPH0114A (ja) リポソーム製剤およびその製造法
Sarangamath et al. Invasomes: A vesicular carrier for transdermal delivery
JPH04503677A (ja) 薬剤学的製剤
US20020076434A1 (en) Liposomal retinoid therapy in hormone refractory prostate cancer
Quang et al. AN INVESTIGATION OF SOME FACTORS OF LIPOSOMAL AMPHOTERICIN B PREPARATION BY FILM HYDRATION METHOD

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee